GRAL Investor Alert: HBSS Probes GRAIL, Inc. (GRAL) Following Securities Class Action Over Failed NHS-Galleri Trial
Hagens Berman is soliciting GRAIL investors to join a class action lawsuit alleging the company misled investors regarding the design and efficacy of its NHS-Galleri trial. The firm references the February 19, 2026 announcement that the trial failed its primary endpoint, which reportedly caused a 50.55% single-day drop in share price.
Key figures
- Share price decline
- 50.55%
- Lead plaintiff deadline
- Aug. 4, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.